nodes	percent_of_prediction	percent_of_DWPC	metapath
Morphine—OPRK1—Progesterone—uterine cancer	0.18	0.247	CbGbCtD
Morphine—UGT2B7—Epirubicin—uterine cancer	0.117	0.161	CbGbCtD
Morphine—UGT1A1—Etoposide—uterine cancer	0.0788	0.108	CbGbCtD
Morphine—CYP2C8—Medroxyprogesterone Acetate—uterine cancer	0.0779	0.107	CbGbCtD
Morphine—CYP2C8—Progesterone—uterine cancer	0.0516	0.0708	CbGbCtD
Morphine—ABCB1—Progesterone—uterine cancer	0.0349	0.0479	CbGbCtD
Morphine—CYP2D6—Progesterone—uterine cancer	0.0329	0.0452	CbGbCtD
Morphine—CYP3A4—Medroxyprogesterone Acetate—uterine cancer	0.0316	0.0434	CbGbCtD
Morphine—ABCB1—Dactinomycin—uterine cancer	0.0277	0.038	CbGbCtD
Morphine—CYP2C8—Etoposide—uterine cancer	0.0231	0.0317	CbGbCtD
Morphine—CYP3A4—Progesterone—uterine cancer	0.0209	0.0287	CbGbCtD
Morphine—ABCB1—Etoposide—uterine cancer	0.0156	0.0214	CbGbCtD
Morphine—ABCB1—Doxorubicin—uterine cancer	0.0107	0.0146	CbGbCtD
Morphine—CYP2D6—Doxorubicin—uterine cancer	0.01	0.0138	CbGbCtD
Morphine—CYP3A4—Etoposide—uterine cancer	0.00936	0.0129	CbGbCtD
Morphine—CYP3A4—Doxorubicin—uterine cancer	0.00639	0.00877	CbGbCtD
Morphine—UGT1A8—renal system—uterine cancer	0.00135	0.132	CbGeAlD
Morphine—OPRL1—female reproductive system—uterine cancer	0.00105	0.103	CbGeAlD
Morphine—UGT2B15—female reproductive system—uterine cancer	0.000905	0.0888	CbGeAlD
Morphine—UGT2B7—renal system—uterine cancer	0.00069	0.0677	CbGeAlD
Morphine—OPRD1—renal system—uterine cancer	0.000677	0.0664	CbGeAlD
Morphine—OPRL1—lymph node—uterine cancer	0.000616	0.0604	CbGeAlD
Morphine—UGT1A1—renal system—uterine cancer	0.000587	0.0576	CbGeAlD
Morphine—UGT2B7—female reproductive system—uterine cancer	0.000553	0.0542	CbGeAlD
Morphine—OPRK1—female reproductive system—uterine cancer	0.00052	0.051	CbGeAlD
Morphine—CYP2C8—renal system—uterine cancer	0.000278	0.0272	CbGeAlD
Morphine—CYP2C8—endometrium—uterine cancer	0.000268	0.0263	CbGeAlD
Morphine—CYP2C8—female reproductive system—uterine cancer	0.000222	0.0218	CbGeAlD
Morphine—CYP2C8—vagina—uterine cancer	0.000201	0.0197	CbGeAlD
Morphine—Diplopia—Doxorubicin—uterine cancer	0.000195	0.000858	CcSEcCtD
Morphine—Liver function test abnormal—Epirubicin—uterine cancer	0.000195	0.000856	CcSEcCtD
Morphine—Nausea—Medroxyprogesterone Acetate—uterine cancer	0.000195	0.000856	CcSEcCtD
Morphine—Dry skin—Epirubicin—uterine cancer	0.000194	0.00085	CcSEcCtD
Morphine—Chest pain—Etoposide—uterine cancer	0.000193	0.000848	CcSEcCtD
Morphine—Abdominal pain upper—Epirubicin—uterine cancer	0.000193	0.000847	CcSEcCtD
Morphine—Orthostatic hypotension—Epirubicin—uterine cancer	0.000193	0.000847	CcSEcCtD
Morphine—Affect lability—Doxorubicin—uterine cancer	0.000192	0.000845	CcSEcCtD
Morphine—Hypokalaemia—Epirubicin—uterine cancer	0.000192	0.000844	CcSEcCtD
Morphine—Unspecified disorder of skin and subcutaneous tissue—Etoposide—uterine cancer	0.000192	0.000842	CcSEcCtD
Morphine—Discomfort—Etoposide—uterine cancer	0.000191	0.000838	CcSEcCtD
Morphine—Breast disorder—Epirubicin—uterine cancer	0.000191	0.000838	CcSEcCtD
Morphine—Nasopharyngitis—Epirubicin—uterine cancer	0.000189	0.000829	CcSEcCtD
Morphine—Hypersensitivity—Dactinomycin—uterine cancer	0.000189	0.000828	CcSEcCtD
Morphine—CYP3A4—renal system—uterine cancer	0.000188	0.0185	CbGeAlD
Morphine—Confusional state—Etoposide—uterine cancer	0.000187	0.00082	CcSEcCtD
Morphine—Cardiac arrest—Doxorubicin—uterine cancer	0.000186	0.000816	CcSEcCtD
Morphine—Anaphylactic shock—Etoposide—uterine cancer	0.000185	0.000813	CcSEcCtD
Morphine—Mood swings—Doxorubicin—uterine cancer	0.000185	0.000813	CcSEcCtD
Morphine—CYP2D6—renal system—uterine cancer	0.000185	0.0182	CbGeAlD
Morphine—Infection—Etoposide—uterine cancer	0.000184	0.000808	CcSEcCtD
Morphine—Abdominal distension—Epirubicin—uterine cancer	0.000184	0.000807	CcSEcCtD
Morphine—Ataxia—Doxorubicin—uterine cancer	0.000184	0.000807	CcSEcCtD
Morphine—Asthenia—Dactinomycin—uterine cancer	0.000184	0.000806	CcSEcCtD
Morphine—ABCB1—myometrium—uterine cancer	0.000183	0.0179	CbGeAlD
Morphine—Influenza—Epirubicin—uterine cancer	0.000183	0.000801	CcSEcCtD
Morphine—Dysphagia—Epirubicin—uterine cancer	0.000183	0.000801	CcSEcCtD
Morphine—Dehydration—Doxorubicin—uterine cancer	0.000182	0.000798	CcSEcCtD
Morphine—Thrombocytopenia—Etoposide—uterine cancer	0.000181	0.000796	CcSEcCtD
Morphine—Tachycardia—Etoposide—uterine cancer	0.000181	0.000794	CcSEcCtD
Morphine—Eosinophilia—Epirubicin—uterine cancer	0.000181	0.000794	CcSEcCtD
Morphine—Liver function test abnormal—Doxorubicin—uterine cancer	0.00018	0.000792	CcSEcCtD
Morphine—Skin disorder—Etoposide—uterine cancer	0.00018	0.00079	CcSEcCtD
Morphine—Dry skin—Doxorubicin—uterine cancer	0.000179	0.000786	CcSEcCtD
Morphine—Hyperhidrosis—Etoposide—uterine cancer	0.000179	0.000786	CcSEcCtD
Morphine—Orthostatic hypotension—Doxorubicin—uterine cancer	0.000178	0.000784	CcSEcCtD
Morphine—Abdominal pain upper—Doxorubicin—uterine cancer	0.000178	0.000784	CcSEcCtD
Morphine—Hypokalaemia—Doxorubicin—uterine cancer	0.000178	0.000781	CcSEcCtD
Morphine—Breast disorder—Doxorubicin—uterine cancer	0.000177	0.000775	CcSEcCtD
Morphine—Anorexia—Etoposide—uterine cancer	0.000177	0.000775	CcSEcCtD
Morphine—Diarrhoea—Dactinomycin—uterine cancer	0.000175	0.000769	CcSEcCtD
Morphine—Nasopharyngitis—Doxorubicin—uterine cancer	0.000175	0.000767	CcSEcCtD
Morphine—Hypotension—Etoposide—uterine cancer	0.000173	0.00076	CcSEcCtD
Morphine—Dysuria—Epirubicin—uterine cancer	0.000171	0.000749	CcSEcCtD
Morphine—Abdominal distension—Doxorubicin—uterine cancer	0.00017	0.000747	CcSEcCtD
Morphine—Influenza—Doxorubicin—uterine cancer	0.000169	0.000742	CcSEcCtD
Morphine—Dysphagia—Doxorubicin—uterine cancer	0.000169	0.000742	CcSEcCtD
Morphine—Eosinophilia—Doxorubicin—uterine cancer	0.000167	0.000734	CcSEcCtD
Morphine—Paraesthesia—Etoposide—uterine cancer	0.000166	0.00073	CcSEcCtD
Morphine—Weight decreased—Epirubicin—uterine cancer	0.000165	0.000725	CcSEcCtD
Morphine—Dyspnoea—Etoposide—uterine cancer	0.000165	0.000725	CcSEcCtD
Morphine—Hyperglycaemia—Epirubicin—uterine cancer	0.000165	0.000723	CcSEcCtD
Morphine—Somnolence—Etoposide—uterine cancer	0.000165	0.000723	CcSEcCtD
Morphine—Drowsiness—Epirubicin—uterine cancer	0.000163	0.000715	CcSEcCtD
Morphine—Vomiting—Dactinomycin—uterine cancer	0.000163	0.000714	CcSEcCtD
Morphine—Rash—Dactinomycin—uterine cancer	0.000161	0.000708	CcSEcCtD
Morphine—Decreased appetite—Etoposide—uterine cancer	0.000161	0.000707	CcSEcCtD
Morphine—Renal failure—Epirubicin—uterine cancer	0.00016	0.000702	CcSEcCtD
Morphine—Gastrointestinal disorder—Etoposide—uterine cancer	0.00016	0.000702	CcSEcCtD
Morphine—Fatigue—Etoposide—uterine cancer	0.00016	0.000701	CcSEcCtD
Morphine—Stomatitis—Epirubicin—uterine cancer	0.000159	0.000697	CcSEcCtD
Morphine—Pain—Etoposide—uterine cancer	0.000158	0.000695	CcSEcCtD
Morphine—Constipation—Etoposide—uterine cancer	0.000158	0.000695	CcSEcCtD
Morphine—Urinary tract infection—Epirubicin—uterine cancer	0.000158	0.000695	CcSEcCtD
Morphine—Conjunctivitis—Epirubicin—uterine cancer	0.000158	0.000695	CcSEcCtD
Morphine—Dysuria—Doxorubicin—uterine cancer	0.000158	0.000693	CcSEcCtD
Morphine—Sweating—Epirubicin—uterine cancer	0.000156	0.000685	CcSEcCtD
Morphine—Hepatobiliary disease—Epirubicin—uterine cancer	0.000154	0.000676	CcSEcCtD
Morphine—Weight decreased—Doxorubicin—uterine cancer	0.000153	0.000671	CcSEcCtD
Morphine—Feeling abnormal—Etoposide—uterine cancer	0.000153	0.00067	CcSEcCtD
Morphine—Hyperglycaemia—Doxorubicin—uterine cancer	0.000152	0.000669	CcSEcCtD
Morphine—Nausea—Dactinomycin—uterine cancer	0.000152	0.000667	CcSEcCtD
Morphine—Gastrointestinal pain—Etoposide—uterine cancer	0.000151	0.000665	CcSEcCtD
Morphine—CYP3A4—female reproductive system—uterine cancer	0.000151	0.0148	CbGeAlD
Morphine—Drowsiness—Doxorubicin—uterine cancer	0.000151	0.000661	CcSEcCtD
Morphine—Bradycardia—Epirubicin—uterine cancer	0.000149	0.000653	CcSEcCtD
Morphine—CYP2D6—female reproductive system—uterine cancer	0.000148	0.0145	CbGeAlD
Morphine—Renal failure—Doxorubicin—uterine cancer	0.000148	0.00065	CcSEcCtD
Morphine—Urticaria—Etoposide—uterine cancer	0.000147	0.000646	CcSEcCtD
Morphine—Stomatitis—Doxorubicin—uterine cancer	0.000147	0.000645	CcSEcCtD
Morphine—Rhinitis—Epirubicin—uterine cancer	0.000146	0.000643	CcSEcCtD
Morphine—Body temperature increased—Etoposide—uterine cancer	0.000146	0.000643	CcSEcCtD
Morphine—Abdominal pain—Etoposide—uterine cancer	0.000146	0.000643	CcSEcCtD
Morphine—Urinary tract infection—Doxorubicin—uterine cancer	0.000146	0.000643	CcSEcCtD
Morphine—Conjunctivitis—Doxorubicin—uterine cancer	0.000146	0.000643	CcSEcCtD
Morphine—Hepatitis—Epirubicin—uterine cancer	0.000146	0.000642	CcSEcCtD
Morphine—Hypoaesthesia—Epirubicin—uterine cancer	0.000145	0.000638	CcSEcCtD
Morphine—Sweating—Doxorubicin—uterine cancer	0.000144	0.000634	CcSEcCtD
Morphine—Urinary tract disorder—Epirubicin—uterine cancer	0.000144	0.000634	CcSEcCtD
Morphine—Oedema peripheral—Epirubicin—uterine cancer	0.000144	0.000632	CcSEcCtD
Morphine—Connective tissue disorder—Epirubicin—uterine cancer	0.000144	0.00063	CcSEcCtD
Morphine—ABCB1—epithelium—uterine cancer	0.000144	0.0141	CbGeAlD
Morphine—Urethral disorder—Epirubicin—uterine cancer	0.000143	0.000629	CcSEcCtD
Morphine—Hepatobiliary disease—Doxorubicin—uterine cancer	0.000142	0.000625	CcSEcCtD
Morphine—ABCB1—uterine cervix—uterine cancer	0.000142	0.014	CbGeAlD
Morphine—Visual impairment—Epirubicin—uterine cancer	0.000141	0.000618	CcSEcCtD
Morphine—Bradycardia—Doxorubicin—uterine cancer	0.000138	0.000604	CcSEcCtD
Morphine—Eye disorder—Epirubicin—uterine cancer	0.000137	0.0006	CcSEcCtD
Morphine—Hypersensitivity—Etoposide—uterine cancer	0.000136	0.000599	CcSEcCtD
Morphine—Flushing—Epirubicin—uterine cancer	0.000136	0.000595	CcSEcCtD
Morphine—ABCB1—decidua—uterine cancer	0.000136	0.0133	CbGeAlD
Morphine—Rhinitis—Doxorubicin—uterine cancer	0.000136	0.000595	CcSEcCtD
Morphine—Hepatitis—Doxorubicin—uterine cancer	0.000135	0.000594	CcSEcCtD
Morphine—CYP2D6—female gonad—uterine cancer	0.000135	0.0132	CbGeAlD
Morphine—Hypoaesthesia—Doxorubicin—uterine cancer	0.000135	0.000591	CcSEcCtD
Morphine—Urinary tract disorder—Doxorubicin—uterine cancer	0.000134	0.000586	CcSEcCtD
Morphine—Oedema peripheral—Doxorubicin—uterine cancer	0.000133	0.000585	CcSEcCtD
Morphine—ABCB1—renal system—uterine cancer	0.000133	0.0131	CbGeAlD
Morphine—Asthenia—Etoposide—uterine cancer	0.000133	0.000583	CcSEcCtD
Morphine—Connective tissue disorder—Doxorubicin—uterine cancer	0.000133	0.000583	CcSEcCtD
Morphine—Angiopathy—Epirubicin—uterine cancer	0.000133	0.000582	CcSEcCtD
Morphine—Urethral disorder—Doxorubicin—uterine cancer	0.000133	0.000582	CcSEcCtD
Morphine—Mediastinal disorder—Epirubicin—uterine cancer	0.000132	0.000578	CcSEcCtD
Morphine—Chills—Epirubicin—uterine cancer	0.000131	0.000576	CcSEcCtD
Morphine—Pruritus—Etoposide—uterine cancer	0.000131	0.000575	CcSEcCtD
Morphine—Visual impairment—Doxorubicin—uterine cancer	0.00013	0.000572	CcSEcCtD
Morphine—ABCB1—endometrium—uterine cancer	0.000129	0.0126	CbGeAlD
Morphine—Mental disorder—Epirubicin—uterine cancer	0.000128	0.000562	CcSEcCtD
Morphine—Malnutrition—Epirubicin—uterine cancer	0.000127	0.000558	CcSEcCtD
Morphine—Erythema—Epirubicin—uterine cancer	0.000127	0.000558	CcSEcCtD
Morphine—Diarrhoea—Etoposide—uterine cancer	0.000127	0.000556	CcSEcCtD
Morphine—Eye disorder—Doxorubicin—uterine cancer	0.000126	0.000555	CcSEcCtD
Morphine—Flushing—Doxorubicin—uterine cancer	0.000125	0.000551	CcSEcCtD
Morphine—Flatulence—Epirubicin—uterine cancer	0.000125	0.00055	CcSEcCtD
Morphine—Tension—Epirubicin—uterine cancer	0.000125	0.000548	CcSEcCtD
Morphine—Dysgeusia—Epirubicin—uterine cancer	0.000125	0.000547	CcSEcCtD
Morphine—ABCB1—mammalian vulva—uterine cancer	0.000124	0.0122	CbGeAlD
Morphine—Nervousness—Epirubicin—uterine cancer	0.000124	0.000542	CcSEcCtD
Morphine—Back pain—Epirubicin—uterine cancer	0.000123	0.00054	CcSEcCtD
Morphine—Angiopathy—Doxorubicin—uterine cancer	0.000123	0.000539	CcSEcCtD
Morphine—Dizziness—Etoposide—uterine cancer	0.000122	0.000538	CcSEcCtD
Morphine—Muscle spasms—Epirubicin—uterine cancer	0.000122	0.000537	CcSEcCtD
Morphine—Mediastinal disorder—Doxorubicin—uterine cancer	0.000122	0.000535	CcSEcCtD
Morphine—Chills—Doxorubicin—uterine cancer	0.000121	0.000533	CcSEcCtD
Morphine—Vision blurred—Epirubicin—uterine cancer	0.00012	0.000526	CcSEcCtD
Morphine—ABCB1—uterus—uterine cancer	0.000119	0.0116	CbGeAlD
Morphine—Mental disorder—Doxorubicin—uterine cancer	0.000118	0.00052	CcSEcCtD
Morphine—Ill-defined disorder—Epirubicin—uterine cancer	0.000118	0.000518	CcSEcCtD
Morphine—Vomiting—Etoposide—uterine cancer	0.000118	0.000517	CcSEcCtD
Morphine—Malnutrition—Doxorubicin—uterine cancer	0.000118	0.000517	CcSEcCtD
Morphine—Erythema—Doxorubicin—uterine cancer	0.000118	0.000517	CcSEcCtD
Morphine—Anaemia—Epirubicin—uterine cancer	0.000118	0.000516	CcSEcCtD
Morphine—Agitation—Epirubicin—uterine cancer	0.000117	0.000513	CcSEcCtD
Morphine—Rash—Etoposide—uterine cancer	0.000117	0.000513	CcSEcCtD
Morphine—Dermatitis—Etoposide—uterine cancer	0.000117	0.000512	CcSEcCtD
Morphine—Headache—Etoposide—uterine cancer	0.000116	0.000509	CcSEcCtD
Morphine—Flatulence—Doxorubicin—uterine cancer	0.000116	0.000509	CcSEcCtD
Morphine—Tension—Doxorubicin—uterine cancer	0.000115	0.000507	CcSEcCtD
Morphine—Dysgeusia—Doxorubicin—uterine cancer	0.000115	0.000506	CcSEcCtD
Morphine—Malaise—Epirubicin—uterine cancer	0.000115	0.000504	CcSEcCtD
Morphine—Nervousness—Doxorubicin—uterine cancer	0.000114	0.000502	CcSEcCtD
Morphine—Vertigo—Epirubicin—uterine cancer	0.000114	0.000502	CcSEcCtD
Morphine—Syncope—Epirubicin—uterine cancer	0.000114	0.000501	CcSEcCtD
Morphine—Leukopenia—Epirubicin—uterine cancer	0.000114	0.0005	CcSEcCtD
Morphine—Back pain—Doxorubicin—uterine cancer	0.000114	0.0005	CcSEcCtD
Morphine—Muscle spasms—Doxorubicin—uterine cancer	0.000113	0.000497	CcSEcCtD
Morphine—Palpitations—Epirubicin—uterine cancer	0.000112	0.000494	CcSEcCtD
Morphine—Loss of consciousness—Epirubicin—uterine cancer	0.000112	0.000491	CcSEcCtD
Morphine—Cough—Epirubicin—uterine cancer	0.000111	0.000487	CcSEcCtD
Morphine—Vision blurred—Doxorubicin—uterine cancer	0.000111	0.000487	CcSEcCtD
Morphine—Convulsion—Epirubicin—uterine cancer	0.00011	0.000484	CcSEcCtD
Morphine—Nausea—Etoposide—uterine cancer	0.00011	0.000483	CcSEcCtD
Morphine—Hypertension—Epirubicin—uterine cancer	0.00011	0.000482	CcSEcCtD
Morphine—Ill-defined disorder—Doxorubicin—uterine cancer	0.000109	0.000479	CcSEcCtD
Morphine—Anaemia—Doxorubicin—uterine cancer	0.000109	0.000478	CcSEcCtD
Morphine—Arthralgia—Epirubicin—uterine cancer	0.000108	0.000475	CcSEcCtD
Morphine—Chest pain—Epirubicin—uterine cancer	0.000108	0.000475	CcSEcCtD
Morphine—Agitation—Doxorubicin—uterine cancer	0.000108	0.000475	CcSEcCtD
Morphine—Anxiety—Epirubicin—uterine cancer	0.000108	0.000474	CcSEcCtD
Morphine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—uterine cancer	0.000108	0.000472	CcSEcCtD
Morphine—Discomfort—Epirubicin—uterine cancer	0.000107	0.00047	CcSEcCtD
Morphine—ABCB1—female reproductive system—uterine cancer	0.000107	0.0105	CbGeAlD
Morphine—Malaise—Doxorubicin—uterine cancer	0.000106	0.000466	CcSEcCtD
Morphine—Dry mouth—Epirubicin—uterine cancer	0.000106	0.000465	CcSEcCtD
Morphine—Vertigo—Doxorubicin—uterine cancer	0.000106	0.000464	CcSEcCtD
Morphine—Syncope—Doxorubicin—uterine cancer	0.000106	0.000463	CcSEcCtD
Morphine—Leukopenia—Doxorubicin—uterine cancer	0.000105	0.000463	CcSEcCtD
Morphine—Confusional state—Epirubicin—uterine cancer	0.000105	0.00046	CcSEcCtD
Morphine—Palpitations—Doxorubicin—uterine cancer	0.000104	0.000457	CcSEcCtD
Morphine—Anaphylactic shock—Epirubicin—uterine cancer	0.000104	0.000456	CcSEcCtD
Morphine—Oedema—Epirubicin—uterine cancer	0.000104	0.000456	CcSEcCtD
Morphine—Loss of consciousness—Doxorubicin—uterine cancer	0.000103	0.000454	CcSEcCtD
Morphine—Infection—Epirubicin—uterine cancer	0.000103	0.000453	CcSEcCtD
Morphine—Cough—Doxorubicin—uterine cancer	0.000103	0.000451	CcSEcCtD
Morphine—Shock—Epirubicin—uterine cancer	0.000102	0.000448	CcSEcCtD
Morphine—Convulsion—Doxorubicin—uterine cancer	0.000102	0.000448	CcSEcCtD
Morphine—Nervous system disorder—Epirubicin—uterine cancer	0.000102	0.000447	CcSEcCtD
Morphine—Thrombocytopenia—Epirubicin—uterine cancer	0.000102	0.000446	CcSEcCtD
Morphine—Hypertension—Doxorubicin—uterine cancer	0.000102	0.000446	CcSEcCtD
Morphine—Tachycardia—Epirubicin—uterine cancer	0.000101	0.000445	CcSEcCtD
Morphine—Skin disorder—Epirubicin—uterine cancer	0.000101	0.000443	CcSEcCtD
Morphine—Hyperhidrosis—Epirubicin—uterine cancer	0.0001	0.000441	CcSEcCtD
Morphine—Chest pain—Doxorubicin—uterine cancer	0.0001	0.00044	CcSEcCtD
Morphine—Arthralgia—Doxorubicin—uterine cancer	0.0001	0.00044	CcSEcCtD
Morphine—Anxiety—Doxorubicin—uterine cancer	9.99e-05	0.000438	CcSEcCtD
Morphine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—uterine cancer	9.95e-05	0.000437	CcSEcCtD
Morphine—Discomfort—Doxorubicin—uterine cancer	9.9e-05	0.000435	CcSEcCtD
Morphine—Anorexia—Epirubicin—uterine cancer	9.9e-05	0.000434	CcSEcCtD
Morphine—Dry mouth—Doxorubicin—uterine cancer	9.8e-05	0.00043	CcSEcCtD
Morphine—ABCB1—female gonad—uterine cancer	9.7e-05	0.00952	CbGeAlD
Morphine—Hypotension—Epirubicin—uterine cancer	9.7e-05	0.000426	CcSEcCtD
Morphine—Confusional state—Doxorubicin—uterine cancer	9.68e-05	0.000425	CcSEcCtD
Morphine—ABCB1—vagina—uterine cancer	9.64e-05	0.00946	CbGeAlD
Morphine—Anaphylactic shock—Doxorubicin—uterine cancer	9.61e-05	0.000422	CcSEcCtD
Morphine—Oedema—Doxorubicin—uterine cancer	9.61e-05	0.000422	CcSEcCtD
Morphine—Infection—Doxorubicin—uterine cancer	9.54e-05	0.000419	CcSEcCtD
Morphine—Musculoskeletal discomfort—Epirubicin—uterine cancer	9.46e-05	0.000415	CcSEcCtD
Morphine—Shock—Doxorubicin—uterine cancer	9.45e-05	0.000415	CcSEcCtD
Morphine—Nervous system disorder—Doxorubicin—uterine cancer	9.42e-05	0.000414	CcSEcCtD
Morphine—Thrombocytopenia—Doxorubicin—uterine cancer	9.4e-05	0.000413	CcSEcCtD
Morphine—Insomnia—Epirubicin—uterine cancer	9.39e-05	0.000412	CcSEcCtD
Morphine—Tachycardia—Doxorubicin—uterine cancer	9.37e-05	0.000412	CcSEcCtD
Morphine—Skin disorder—Doxorubicin—uterine cancer	9.33e-05	0.00041	CcSEcCtD
Morphine—Paraesthesia—Epirubicin—uterine cancer	9.32e-05	0.000409	CcSEcCtD
Morphine—Hyperhidrosis—Doxorubicin—uterine cancer	9.29e-05	0.000408	CcSEcCtD
Morphine—Dyspnoea—Epirubicin—uterine cancer	9.25e-05	0.000406	CcSEcCtD
Morphine—Somnolence—Epirubicin—uterine cancer	9.23e-05	0.000405	CcSEcCtD
Morphine—Anorexia—Doxorubicin—uterine cancer	9.16e-05	0.000402	CcSEcCtD
Morphine—Dyspepsia—Epirubicin—uterine cancer	9.14e-05	0.000401	CcSEcCtD
Morphine—Decreased appetite—Epirubicin—uterine cancer	9.02e-05	0.000396	CcSEcCtD
Morphine—Hypotension—Doxorubicin—uterine cancer	8.98e-05	0.000394	CcSEcCtD
Morphine—Gastrointestinal disorder—Epirubicin—uterine cancer	8.96e-05	0.000393	CcSEcCtD
Morphine—Fatigue—Epirubicin—uterine cancer	8.95e-05	0.000393	CcSEcCtD
Morphine—Pain—Epirubicin—uterine cancer	8.88e-05	0.00039	CcSEcCtD
Morphine—Constipation—Epirubicin—uterine cancer	8.88e-05	0.00039	CcSEcCtD
Morphine—Musculoskeletal discomfort—Doxorubicin—uterine cancer	8.75e-05	0.000384	CcSEcCtD
Morphine—Insomnia—Doxorubicin—uterine cancer	8.69e-05	0.000381	CcSEcCtD
Morphine—Paraesthesia—Doxorubicin—uterine cancer	8.62e-05	0.000379	CcSEcCtD
Morphine—Dyspnoea—Doxorubicin—uterine cancer	8.56e-05	0.000376	CcSEcCtD
Morphine—Feeling abnormal—Epirubicin—uterine cancer	8.55e-05	0.000376	CcSEcCtD
Morphine—Somnolence—Doxorubicin—uterine cancer	8.54e-05	0.000375	CcSEcCtD
Morphine—Gastrointestinal pain—Epirubicin—uterine cancer	8.49e-05	0.000373	CcSEcCtD
Morphine—Dyspepsia—Doxorubicin—uterine cancer	8.46e-05	0.000371	CcSEcCtD
Morphine—Decreased appetite—Doxorubicin—uterine cancer	8.35e-05	0.000367	CcSEcCtD
Morphine—Gastrointestinal disorder—Doxorubicin—uterine cancer	8.29e-05	0.000364	CcSEcCtD
Morphine—Fatigue—Doxorubicin—uterine cancer	8.28e-05	0.000364	CcSEcCtD
Morphine—Urticaria—Epirubicin—uterine cancer	8.25e-05	0.000362	CcSEcCtD
Morphine—Pain—Doxorubicin—uterine cancer	8.21e-05	0.000361	CcSEcCtD
Morphine—Constipation—Doxorubicin—uterine cancer	8.21e-05	0.000361	CcSEcCtD
Morphine—Abdominal pain—Epirubicin—uterine cancer	8.21e-05	0.00036	CcSEcCtD
Morphine—Body temperature increased—Epirubicin—uterine cancer	8.21e-05	0.00036	CcSEcCtD
Morphine—Feeling abnormal—Doxorubicin—uterine cancer	7.92e-05	0.000348	CcSEcCtD
Morphine—Gastrointestinal pain—Doxorubicin—uterine cancer	7.85e-05	0.000345	CcSEcCtD
Morphine—Hypersensitivity—Epirubicin—uterine cancer	7.65e-05	0.000336	CcSEcCtD
Morphine—Urticaria—Doxorubicin—uterine cancer	7.63e-05	0.000335	CcSEcCtD
Morphine—Abdominal pain—Doxorubicin—uterine cancer	7.59e-05	0.000333	CcSEcCtD
Morphine—Body temperature increased—Doxorubicin—uterine cancer	7.59e-05	0.000333	CcSEcCtD
Morphine—Asthenia—Epirubicin—uterine cancer	7.45e-05	0.000327	CcSEcCtD
Morphine—Pruritus—Epirubicin—uterine cancer	7.34e-05	0.000322	CcSEcCtD
Morphine—Diarrhoea—Epirubicin—uterine cancer	7.1e-05	0.000312	CcSEcCtD
Morphine—Hypersensitivity—Doxorubicin—uterine cancer	7.08e-05	0.000311	CcSEcCtD
Morphine—Asthenia—Doxorubicin—uterine cancer	6.89e-05	0.000303	CcSEcCtD
Morphine—Dizziness—Epirubicin—uterine cancer	6.86e-05	0.000301	CcSEcCtD
Morphine—Pruritus—Doxorubicin—uterine cancer	6.8e-05	0.000298	CcSEcCtD
Morphine—Vomiting—Epirubicin—uterine cancer	6.6e-05	0.00029	CcSEcCtD
Morphine—Diarrhoea—Doxorubicin—uterine cancer	6.57e-05	0.000289	CcSEcCtD
Morphine—Rash—Epirubicin—uterine cancer	6.55e-05	0.000287	CcSEcCtD
Morphine—Dermatitis—Epirubicin—uterine cancer	6.54e-05	0.000287	CcSEcCtD
Morphine—Headache—Epirubicin—uterine cancer	6.5e-05	0.000286	CcSEcCtD
Morphine—Dizziness—Doxorubicin—uterine cancer	6.35e-05	0.000279	CcSEcCtD
Morphine—ABCB1—lymph node—uterine cancer	6.24e-05	0.00612	CbGeAlD
Morphine—Nausea—Epirubicin—uterine cancer	6.17e-05	0.000271	CcSEcCtD
Morphine—Vomiting—Doxorubicin—uterine cancer	6.11e-05	0.000268	CcSEcCtD
Morphine—Rash—Doxorubicin—uterine cancer	6.06e-05	0.000266	CcSEcCtD
Morphine—Dermatitis—Doxorubicin—uterine cancer	6.05e-05	0.000266	CcSEcCtD
Morphine—Headache—Doxorubicin—uterine cancer	6.02e-05	0.000264	CcSEcCtD
Morphine—Nausea—Doxorubicin—uterine cancer	5.71e-05	0.00025	CcSEcCtD
Morphine—OPRM1—GPCR ligand binding—CCL2—uterine cancer	2.81e-05	0.000839	CbGpPWpGaD
Morphine—UGT2B7—Metabolism—AKR1C3—uterine cancer	2.8e-05	0.000835	CbGpPWpGaD
Morphine—OPRL1—Signaling Pathways—CCL2—uterine cancer	2.69e-05	0.000804	CbGpPWpGaD
Morphine—CYP2C8—Metabolism of lipids and lipoproteins—AKR1C3—uterine cancer	2.69e-05	0.000803	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—INHBA—uterine cancer	2.68e-05	0.000801	CbGpPWpGaD
Morphine—UGT1A1—Metabolism—RRM2—uterine cancer	2.63e-05	0.000786	CbGpPWpGaD
Morphine—OPRK1—GPCR ligand binding—CXCL8—uterine cancer	2.63e-05	0.000785	CbGpPWpGaD
Morphine—UGT1A3—Metabolism—STK11—uterine cancer	2.56e-05	0.000765	CbGpPWpGaD
Morphine—UGT1A3—Metabolism—CYP19A1—uterine cancer	2.56e-05	0.000765	CbGpPWpGaD
Morphine—UGT1A1—Metabolism—DCN—uterine cancer	2.55e-05	0.000763	CbGpPWpGaD
Morphine—ABCB1—Metabolism—NDUFB11—uterine cancer	2.55e-05	0.000762	CbGpPWpGaD
Morphine—ABCB1—Metabolism—SRD5A2—uterine cancer	2.55e-05	0.000762	CbGpPWpGaD
Morphine—OPRL1—GPCR downstream signaling—PIK3CA—uterine cancer	2.51e-05	0.000751	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—AKR1C3—uterine cancer	2.51e-05	0.000749	CbGpPWpGaD
Morphine—Naloxone—ESR1—uterine cancer	2.5e-05	1	CrCbGaD
Morphine—OPRL1—Signaling by GPCR—KRAS—uterine cancer	2.49e-05	0.000743	CbGpPWpGaD
Morphine—ABCB1—HIF-1-alpha transcription factor network—AKT1—uterine cancer	2.46e-05	0.000735	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—PGR—uterine cancer	2.44e-05	0.00073	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—AKR1C1—uterine cancer	2.41e-05	0.000721	CbGpPWpGaD
Morphine—UGT1A1—Metabolism—CYP11A1—uterine cancer	2.41e-05	0.000719	CbGpPWpGaD
Morphine—CYP2D6—Metabolism—SRD5A2—uterine cancer	2.4e-05	0.000718	CbGpPWpGaD
Morphine—CYP2D6—Metabolism—NDUFB11—uterine cancer	2.4e-05	0.000718	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—YWHAE—uterine cancer	2.33e-05	0.000696	CbGpPWpGaD
Morphine—UGT1A8—Metabolism—PTEN—uterine cancer	2.29e-05	0.000683	CbGpPWpGaD
Morphine—OPRL1—Signaling by GPCR—PIK3CA—uterine cancer	2.28e-05	0.000682	CbGpPWpGaD
Morphine—UGT1A1—Metabolism—AKR1C3—uterine cancer	2.27e-05	0.000679	CbGpPWpGaD
Morphine—OPRL1—Signaling Pathways—ERBB2—uterine cancer	2.24e-05	0.00067	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—FBXW7—uterine cancer	2.23e-05	0.000667	CbGpPWpGaD
Morphine—OPRM1—GPCR ligand binding—CXCL8—uterine cancer	2.22e-05	0.000663	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—AKR1C3—uterine cancer	2.2e-05	0.000657	CbGpPWpGaD
Morphine—UGT1A8—Metabolism—EP300—uterine cancer	2.18e-05	0.000652	CbGpPWpGaD
Morphine—UGT2B7—Metabolism—STK11—uterine cancer	2.18e-05	0.000651	CbGpPWpGaD
Morphine—UGT2B7—Metabolism—CYP19A1—uterine cancer	2.18e-05	0.000651	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—PGR—uterine cancer	2.14e-05	0.00064	CbGpPWpGaD
Morphine—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—uterine cancer	2.14e-05	0.000639	CbGpPWpGaD
Morphine—OPRL1—Signaling Pathways—CXCL8—uterine cancer	2.13e-05	0.000635	CbGpPWpGaD
Morphine—CYP2C8—Metabolism—AKR1B1—uterine cancer	2.12e-05	0.000633	CbGpPWpGaD
Morphine—CYP2C8—Metabolism—STAR—uterine cancer	2.12e-05	0.000633	CbGpPWpGaD
Morphine—OPRL1—Signaling by GPCR—HRAS—uterine cancer	2.11e-05	0.000631	CbGpPWpGaD
Morphine—CYP2C8—Metabolism of lipids and lipoproteins—CYP19A1—uterine cancer	2.09e-05	0.000625	CbGpPWpGaD
Morphine—OPRL1—Signaling Pathways—CDKN1B—uterine cancer	2.08e-05	0.000621	CbGpPWpGaD
Morphine—OPRL1—GPCR downstream signaling—AKT1—uterine cancer	2.05e-05	0.000614	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—YWHAE—uterine cancer	2.04e-05	0.00061	CbGpPWpGaD
Morphine—UGT2B4—Metabolism—PTEN—uterine cancer	2e-05	0.000597	CbGpPWpGaD
Morphine—UGT2B15—Metabolism—PTEN—uterine cancer	2e-05	0.000597	CbGpPWpGaD
Morphine—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1B—uterine cancer	1.98e-05	0.000592	CbGpPWpGaD
Morphine—OPRL1—Signaling Pathways—CTNNB1—uterine cancer	1.96e-05	0.000586	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—FBXW7—uterine cancer	1.96e-05	0.000585	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—STK11—uterine cancer	1.95e-05	0.000583	CbGpPWpGaD
Morphine—OPRD1—Signaling by GPCR—CCL2—uterine cancer	1.94e-05	0.000581	CbGpPWpGaD
Morphine—UGT1A3—Metabolism—MTHFR—uterine cancer	1.92e-05	0.000575	CbGpPWpGaD
Morphine—OPRL1—Signaling Pathways—PTEN—uterine cancer	1.91e-05	0.000571	CbGpPWpGaD
Morphine—UGT2B4—Metabolism—EP300—uterine cancer	1.91e-05	0.00057	CbGpPWpGaD
Morphine—UGT2B15—Metabolism—EP300—uterine cancer	1.91e-05	0.00057	CbGpPWpGaD
Morphine—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—uterine cancer	1.87e-05	0.000559	CbGpPWpGaD
Morphine—OPRL1—Signaling by GPCR—AKT1—uterine cancer	1.87e-05	0.000557	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—AKR1C3—uterine cancer	1.86e-05	0.000555	CbGpPWpGaD
Morphine—ABCB1—Metabolism—AKR1B1—uterine cancer	1.84e-05	0.000551	CbGpPWpGaD
Morphine—ABCB1—Metabolism—STAR—uterine cancer	1.84e-05	0.000551	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—SOCS3—uterine cancer	1.83e-05	0.000546	CbGpPWpGaD
Morphine—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—uterine cancer	1.82e-05	0.000545	CbGpPWpGaD
Morphine—OPRL1—Signaling Pathways—EP300—uterine cancer	1.82e-05	0.000545	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—PGR—uterine cancer	1.81e-05	0.000541	CbGpPWpGaD
Morphine—UGT1A1—Metabolism—STK11—uterine cancer	1.77e-05	0.000529	CbGpPWpGaD
Morphine—UGT1A1—Metabolism—CYP19A1—uterine cancer	1.77e-05	0.000529	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—CDKN2B—uterine cancer	1.75e-05	0.000523	CbGpPWpGaD
Morphine—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—uterine cancer	1.74e-05	0.00052	CbGpPWpGaD
Morphine—CYP2D6—Metabolism—STAR—uterine cancer	1.74e-05	0.000519	CbGpPWpGaD
Morphine—CYP2D6—Metabolism—AKR1B1—uterine cancer	1.74e-05	0.000519	CbGpPWpGaD
Morphine—OPRL1—Signaling Pathways—VEGFA—uterine cancer	1.73e-05	0.000516	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—YWHAE—uterine cancer	1.73e-05	0.000516	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—STK11—uterine cancer	1.71e-05	0.000512	CbGpPWpGaD
Morphine—OPRL1—Signaling Pathways—NRAS—uterine cancer	1.71e-05	0.00051	CbGpPWpGaD
Morphine—OPRK1—Signaling by GPCR—CCL2—uterine cancer	1.7e-05	0.000509	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—IGF1R—uterine cancer	1.7e-05	0.000508	CbGpPWpGaD
Morphine—OPRD1—GPCR downstream signaling—CXCL8—uterine cancer	1.69e-05	0.000506	CbGpPWpGaD
Morphine—CYP2C8—Metabolism—POLD1—uterine cancer	1.66e-05	0.000496	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—FBXW7—uterine cancer	1.66e-05	0.000495	CbGpPWpGaD
Morphine—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—uterine cancer	1.65e-05	0.000493	CbGpPWpGaD
Morphine—UGT2B7—Metabolism—MTHFR—uterine cancer	1.64e-05	0.000489	CbGpPWpGaD
Morphine—UGT1A8—Metabolism—PIK3CA—uterine cancer	1.61e-05	0.000482	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—SOCS3—uterine cancer	1.6e-05	0.000479	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—SMAD3—uterine cancer	1.6e-05	0.000478	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—NDUFB11—uterine cancer	1.57e-05	0.00047	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—SRD5A2—uterine cancer	1.57e-05	0.00047	CbGpPWpGaD
Morphine—CYP2C8—Metabolism—AKR1C1—uterine cancer	1.55e-05	0.000464	CbGpPWpGaD
Morphine—OPRD1—Signaling by GPCR—CXCL8—uterine cancer	1.54e-05	0.000459	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—CDKN2B—uterine cancer	1.53e-05	0.000459	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—FGFR2—uterine cancer	1.52e-05	0.000455	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—IGF1R—uterine cancer	1.49e-05	0.000445	CbGpPWpGaD
Morphine—OPRK1—GPCR downstream signaling—CXCL8—uterine cancer	1.48e-05	0.000443	CbGpPWpGaD
Morphine—OPRL1—Signaling Pathways—KRAS—uterine cancer	1.47e-05	0.000439	CbGpPWpGaD
Morphine—ABCB1—Metabolism—POLD1—uterine cancer	1.45e-05	0.000432	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—STK11—uterine cancer	1.45e-05	0.000432	CbGpPWpGaD
Morphine—OPRM1—Signaling by GPCR—CCL2—uterine cancer	1.44e-05	0.00043	CbGpPWpGaD
Morphine—UGT2B4—Metabolism—PIK3CA—uterine cancer	1.41e-05	0.000421	CbGpPWpGaD
Morphine—UGT2B15—Metabolism—PIK3CA—uterine cancer	1.41e-05	0.000421	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—SMAD3—uterine cancer	1.4e-05	0.000419	CbGpPWpGaD
Morphine—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—uterine cancer	1.4e-05	0.000419	CbGpPWpGaD
Morphine—CYP2C8—Metabolism—RRM2—uterine cancer	1.38e-05	0.000414	CbGpPWpGaD
Morphine—CYP2D6—Metabolism—POLD1—uterine cancer	1.36e-05	0.000407	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—SOCS3—uterine cancer	1.35e-05	0.000405	CbGpPWpGaD
Morphine—ABCB1—Metabolism—AKR1C1—uterine cancer	1.35e-05	0.000404	CbGpPWpGaD
Morphine—OPRL1—Signaling Pathways—PIK3CA—uterine cancer	1.35e-05	0.000403	CbGpPWpGaD
Morphine—OPRK1—Signaling by GPCR—CXCL8—uterine cancer	1.35e-05	0.000403	CbGpPWpGaD
Morphine—CYP2C8—Metabolism—DCN—uterine cancer	1.34e-05	0.000402	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—FGFR2—uterine cancer	1.34e-05	0.000399	CbGpPWpGaD
Morphine—UGT1A1—Metabolism—MTHFR—uterine cancer	1.33e-05	0.000397	CbGpPWpGaD
Morphine—UGT1A8—Metabolism—AKT1—uterine cancer	1.32e-05	0.000394	CbGpPWpGaD
Morphine—OPRL1—Signaling Pathways—TP53—uterine cancer	1.31e-05	0.00039	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—ESR1—uterine cancer	1.3e-05	0.00039	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—CDKN2B—uterine cancer	1.3e-05	0.000388	CbGpPWpGaD
Morphine—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—uterine cancer	1.29e-05	0.000385	CbGpPWpGaD
Morphine—CYP2D6—Metabolism—AKR1C1—uterine cancer	1.28e-05	0.000381	CbGpPWpGaD
Morphine—CYP2C8—Metabolism—CYP11A1—uterine cancer	1.27e-05	0.000378	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—IGF1R—uterine cancer	1.26e-05	0.000376	CbGpPWpGaD
Morphine—OPRM1—GPCR downstream signaling—CXCL8—uterine cancer	1.25e-05	0.000375	CbGpPWpGaD
Morphine—OPRL1—Signaling Pathways—HRAS—uterine cancer	1.25e-05	0.000373	CbGpPWpGaD
Morphine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—uterine cancer	1.25e-05	0.000372	CbGpPWpGaD
Morphine—OPRD1—Signaling by GPCR—NRAS—uterine cancer	1.23e-05	0.000368	CbGpPWpGaD
Morphine—ABCB1—Metabolism—RRM2—uterine cancer	1.21e-05	0.00036	CbGpPWpGaD
Morphine—CYP2C8—Metabolism—AKR1C3—uterine cancer	1.2e-05	0.000357	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—SMAD3—uterine cancer	1.18e-05	0.000354	CbGpPWpGaD
Morphine—ABCB1—Metabolism—DCN—uterine cancer	1.17e-05	0.00035	CbGpPWpGaD
Morphine—UGT2B4—Metabolism—AKT1—uterine cancer	1.15e-05	0.000344	CbGpPWpGaD
Morphine—UGT2B15—Metabolism—AKT1—uterine cancer	1.15e-05	0.000344	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—CCL2—uterine cancer	1.15e-05	0.000343	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—ESR1—uterine cancer	1.14e-05	0.000342	CbGpPWpGaD
Morphine—OPRM1—Signaling by GPCR—CXCL8—uterine cancer	1.14e-05	0.00034	CbGpPWpGaD
Morphine—CYP2D6—Metabolism—RRM2—uterine cancer	1.14e-05	0.00034	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—STAR—uterine cancer	1.14e-05	0.00034	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—AKR1B1—uterine cancer	1.14e-05	0.00034	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—FGFR2—uterine cancer	1.13e-05	0.000338	CbGpPWpGaD
Morphine—CYP2D6—Metabolism—DCN—uterine cancer	1.1e-05	0.00033	CbGpPWpGaD
Morphine—ABCB1—Metabolism—CYP11A1—uterine cancer	1.1e-05	0.00033	CbGpPWpGaD
Morphine—OPRL1—Signaling Pathways—AKT1—uterine cancer	1.1e-05	0.000329	CbGpPWpGaD
Morphine—OPRK1—Signaling by GPCR—NRAS—uterine cancer	1.08e-05	0.000323	CbGpPWpGaD
Morphine—OPRD1—GPCR downstream signaling—PIK3CA—uterine cancer	1.07e-05	0.000321	CbGpPWpGaD
Morphine—UGT1A3—Metabolism—PTEN—uterine cancer	1.07e-05	0.00032	CbGpPWpGaD
Morphine—OPRD1—Signaling by GPCR—KRAS—uterine cancer	1.06e-05	0.000317	CbGpPWpGaD
Morphine—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—uterine cancer	1.05e-05	0.000314	CbGpPWpGaD
Morphine—ABCB1—Metabolism—AKR1C3—uterine cancer	1.04e-05	0.000311	CbGpPWpGaD
Morphine—CYP2D6—Metabolism—CYP11A1—uterine cancer	1.04e-05	0.000311	CbGpPWpGaD
Morphine—UGT1A3—Metabolism—EP300—uterine cancer	1.02e-05	0.000305	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—CCL2—uterine cancer	1.01e-05	0.000301	CbGpPWpGaD
Morphine—CYP2D6—Metabolism—AKR1C3—uterine cancer	9.82e-06	0.000293	CbGpPWpGaD
Morphine—OPRD1—Signaling by GPCR—PIK3CA—uterine cancer	9.75e-06	0.000291	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—ESR1—uterine cancer	9.66e-06	0.000289	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—ERBB2—uterine cancer	9.57e-06	0.000286	CbGpPWpGaD
Morphine—OPRK1—GPCR downstream signaling—PIK3CA—uterine cancer	9.41e-06	0.000281	CbGpPWpGaD
Morphine—CYP2C8—Metabolism—STK11—uterine cancer	9.32e-06	0.000278	CbGpPWpGaD
Morphine—CYP2C8—Metabolism—CYP19A1—uterine cancer	9.32e-06	0.000278	CbGpPWpGaD
Morphine—OPRK1—Signaling by GPCR—KRAS—uterine cancer	9.3e-06	0.000278	CbGpPWpGaD
Morphine—OPRM1—Signaling by GPCR—NRAS—uterine cancer	9.14e-06	0.000273	CbGpPWpGaD
Morphine—UGT2B7—Metabolism—PTEN—uterine cancer	9.1e-06	0.000272	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—CXCL8—uterine cancer	9.08e-06	0.000271	CbGpPWpGaD
Morphine—OPRD1—Signaling by GPCR—HRAS—uterine cancer	9.02e-06	0.000269	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—POLD1—uterine cancer	8.92e-06	0.000266	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—CDKN1B—uterine cancer	8.86e-06	0.000265	CbGpPWpGaD
Morphine—OPRD1—GPCR downstream signaling—AKT1—uterine cancer	8.77e-06	0.000262	CbGpPWpGaD
Morphine—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	8.75e-06	0.000261	CbGpPWpGaD
Morphine—UGT2B7—Metabolism—EP300—uterine cancer	8.68e-06	0.000259	CbGpPWpGaD
Morphine—OPRK1—Signaling by GPCR—PIK3CA—uterine cancer	8.55e-06	0.000255	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—CCL2—uterine cancer	8.51e-06	0.000254	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—ERBB2—uterine cancer	8.39e-06	0.000251	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—CTNNB1—uterine cancer	8.37e-06	0.00025	CbGpPWpGaD
Morphine—CYP2C8—Metabolism of lipids and lipoproteins—EP300—uterine cancer	8.34e-06	0.000249	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—AKR1C1—uterine cancer	8.34e-06	0.000249	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—PTEN—uterine cancer	8.16e-06	0.000244	CbGpPWpGaD
Morphine—ABCB1—Metabolism—CYP19A1—uterine cancer	8.12e-06	0.000243	CbGpPWpGaD
Morphine—ABCB1—Metabolism—STK11—uterine cancer	8.12e-06	0.000243	CbGpPWpGaD
Morphine—OPRD1—Signaling by GPCR—AKT1—uterine cancer	7.96e-06	0.000238	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—CXCL8—uterine cancer	7.96e-06	0.000238	CbGpPWpGaD
Morphine—OPRM1—GPCR downstream signaling—PIK3CA—uterine cancer	7.96e-06	0.000238	CbGpPWpGaD
Morphine—OPRK1—Signaling by GPCR—HRAS—uterine cancer	7.91e-06	0.000236	CbGpPWpGaD
Morphine—OPRM1—Signaling by GPCR—KRAS—uterine cancer	7.86e-06	0.000235	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—EP300—uterine cancer	7.78e-06	0.000233	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—CDKN1B—uterine cancer	7.77e-06	0.000232	CbGpPWpGaD
Morphine—OPRK1—GPCR downstream signaling—AKT1—uterine cancer	7.69e-06	0.00023	CbGpPWpGaD
Morphine—CYP2D6—Metabolism—STK11—uterine cancer	7.65e-06	0.000229	CbGpPWpGaD
Morphine—CYP2D6—Metabolism—CYP19A1—uterine cancer	7.65e-06	0.000229	CbGpPWpGaD
Morphine—UGT1A3—Metabolism—PIK3CA—uterine cancer	7.55e-06	0.000226	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—RRM2—uterine cancer	7.43e-06	0.000222	CbGpPWpGaD
Morphine—UGT1A1—Metabolism—PTEN—uterine cancer	7.4e-06	0.000221	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—VEGFA—uterine cancer	7.37e-06	0.00022	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—CTNNB1—uterine cancer	7.34e-06	0.000219	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—NRAS—uterine cancer	7.28e-06	0.000218	CbGpPWpGaD
Morphine—OPRM1—Signaling by GPCR—PIK3CA—uterine cancer	7.22e-06	0.000216	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—DCN—uterine cancer	7.22e-06	0.000216	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—PTEN—uterine cancer	7.16e-06	0.000214	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—ERBB2—uterine cancer	7.09e-06	0.000212	CbGpPWpGaD
Morphine—UGT1A1—Metabolism—EP300—uterine cancer	7.06e-06	0.000211	CbGpPWpGaD
Morphine—CYP2C8—Metabolism—MTHFR—uterine cancer	7e-06	0.000209	CbGpPWpGaD
Morphine—OPRK1—Signaling by GPCR—AKT1—uterine cancer	6.98e-06	0.000209	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—EP300—uterine cancer	6.83e-06	0.000204	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—CYP11A1—uterine cancer	6.8e-06	0.000203	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—CXCL8—uterine cancer	6.73e-06	0.000201	CbGpPWpGaD
Morphine—OPRM1—Signaling by GPCR—HRAS—uterine cancer	6.68e-06	0.0002	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—CDKN1B—uterine cancer	6.57e-06	0.000196	CbGpPWpGaD
Morphine—OPRM1—GPCR downstream signaling—AKT1—uterine cancer	6.5e-06	0.000194	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—VEGFA—uterine cancer	6.46e-06	0.000193	CbGpPWpGaD
Morphine—UGT2B7—Metabolism—PIK3CA—uterine cancer	6.42e-06	0.000192	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—AKR1C3—uterine cancer	6.42e-06	0.000192	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—NRAS—uterine cancer	6.39e-06	0.000191	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—KRAS—uterine cancer	6.27e-06	0.000187	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—CTNNB1—uterine cancer	6.21e-06	0.000185	CbGpPWpGaD
Morphine—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	6.17e-06	0.000184	CbGpPWpGaD
Morphine—UGT1A3—Metabolism—AKT1—uterine cancer	6.17e-06	0.000184	CbGpPWpGaD
Morphine—ABCB1—Metabolism—MTHFR—uterine cancer	6.1e-06	0.000182	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—PTEN—uterine cancer	6.05e-06	0.000181	CbGpPWpGaD
Morphine—OPRM1—Signaling by GPCR—AKT1—uterine cancer	5.9e-06	0.000176	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—EP300—uterine cancer	5.77e-06	0.000172	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—PIK3CA—uterine cancer	5.76e-06	0.000172	CbGpPWpGaD
Morphine—CYP2D6—Metabolism—MTHFR—uterine cancer	5.75e-06	0.000172	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—TP53—uterine cancer	5.57e-06	0.000166	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—KRAS—uterine cancer	5.5e-06	0.000164	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—VEGFA—uterine cancer	5.46e-06	0.000163	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—NRAS—uterine cancer	5.4e-06	0.000161	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—HRAS—uterine cancer	5.33e-06	0.000159	CbGpPWpGaD
Morphine—UGT2B7—Metabolism—AKT1—uterine cancer	5.25e-06	0.000157	CbGpPWpGaD
Morphine—UGT1A1—Metabolism—PIK3CA—uterine cancer	5.22e-06	0.000156	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—PIK3CA—uterine cancer	5.05e-06	0.000151	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—STK11—uterine cancer	5e-06	0.000149	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—CYP19A1—uterine cancer	5e-06	0.000149	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—TP53—uterine cancer	4.88e-06	0.000146	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—AKT1—uterine cancer	4.7e-06	0.000141	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—HRAS—uterine cancer	4.67e-06	0.00014	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—KRAS—uterine cancer	4.64e-06	0.000139	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—PIK3CA—uterine cancer	4.27e-06	0.000128	CbGpPWpGaD
Morphine—UGT1A1—Metabolism—AKT1—uterine cancer	4.26e-06	0.000127	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—TP53—uterine cancer	4.13e-06	0.000123	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—AKT1—uterine cancer	4.12e-06	0.000123	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—HRAS—uterine cancer	3.95e-06	0.000118	CbGpPWpGaD
Morphine—CYP2C8—Metabolism—PTEN—uterine cancer	3.9e-06	0.000116	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—MTHFR—uterine cancer	3.76e-06	0.000112	CbGpPWpGaD
Morphine—CYP2C8—Metabolism—EP300—uterine cancer	3.72e-06	0.000111	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—AKT1—uterine cancer	3.49e-06	0.000104	CbGpPWpGaD
Morphine—ABCB1—Metabolism—PTEN—uterine cancer	3.39e-06	0.000101	CbGpPWpGaD
Morphine—ABCB1—Metabolism—EP300—uterine cancer	3.24e-06	9.67e-05	CbGpPWpGaD
Morphine—CYP2D6—Metabolism—PTEN—uterine cancer	3.2e-06	9.56e-05	CbGpPWpGaD
Morphine—CYP2D6—Metabolism—EP300—uterine cancer	3.05e-06	9.11e-05	CbGpPWpGaD
Morphine—CYP2C8—Metabolism—PIK3CA—uterine cancer	2.75e-06	8.21e-05	CbGpPWpGaD
Morphine—ABCB1—Metabolism—PIK3CA—uterine cancer	2.39e-06	7.15e-05	CbGpPWpGaD
Morphine—CYP2D6—Metabolism—PIK3CA—uterine cancer	2.26e-06	6.74e-05	CbGpPWpGaD
Morphine—CYP2C8—Metabolism—AKT1—uterine cancer	2.25e-06	6.71e-05	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—PTEN—uterine cancer	2.09e-06	6.25e-05	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—EP300—uterine cancer	1.99e-06	5.96e-05	CbGpPWpGaD
Morphine—ABCB1—Metabolism—AKT1—uterine cancer	1.96e-06	5.84e-05	CbGpPWpGaD
Morphine—CYP2D6—Metabolism—AKT1—uterine cancer	1.84e-06	5.51e-05	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—PIK3CA—uterine cancer	1.48e-06	4.41e-05	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—AKT1—uterine cancer	1.21e-06	3.6e-05	CbGpPWpGaD
